MatsukiyoCocokara & Co - Company Profile
Powered by 
All the sales intelligence you need on MatsukiyoCocokara & Co in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how MatsukiyoCocokara & Co fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with MatsukiyoCocokara & Co.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
MatsukiyoCocokara & Co (MatsukiyoCocokara) is a retailer that operates a chain of drug stores and pharmacies. Its product portfolio includes cosmetics, health care products, medical and pharmaceutical products, general merchandise, and food products. The company markets products under matsukiyo, Argelan, The Retinotime, and matsukiyo LAB brand names. MatsukiyoCocokara also has healthcare lounge, beautycare studio, and supplement bar. Its other business activities include wholesale trade of pharmaceuticals, and advertising. The company is also involved in specialized medicine and home healthcare fields. It operates stores in Japan, Taiwan, Thailand, Hong Kong, and Vietnam. Matsumotokiyoshi is headquartered in Bunkyo-Ku, Tokyo, Japan.
Headquarters
Japan
Address
7f, Mk Ochanomizu Bldg., 1-8-2, Yushima, Bunkyo, Tokyo, 113-0034
Website
www.matsukiyococokara.com
Telephone
81 3 68450005
No of Employees
46,000
Industry
Retailing
Ticker Symbol & Exchange
3088 (TYO)
Revenue (2025)
$7.2B
5.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
2%
(2025 vs 2024)
Market Cap*
$6.2B
Net Profit Margin (2025)
XYZ
-3.1%
(2025 vs 2024)
* As of and is in US$
MatsukiyoCocokara & Co premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Wholesale | : |
| Retailing | Matsukiyo |
| Advertising | Matsukiyo LAB |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Plans/Strategy | In August, the company's subsidiary announced its plans to acquire a 100% stake in Shinseidoyakkyoku Co. Ltd. |
| 2024 | Contracts/Agreements | In June, the company entered into a partnership with Revieve to apply AI customer solutions. |
| 2024 | Acquisitions/Mergers/Takeovers | In January, the company announced the plans to acquire K-PORT Co., Ltd. |
Competitor Comparison
| Key Parameters | MatsukiyoCocokara & Co | Sugi Holdings Co Ltd | Create SD Holdings Co Ltd | Ain Holdings Inc | Pharmarise Holdings Corp |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Bunkyo | Obu-Shi | Yokohama-Shi | Sapporo-Shi | Nakano-Ku |
| State/Province | Tokyo | Aichi | Kanagawa | Hokkaido | Tokyo |
| No. of Employees | 46,000 | 13,417 | 5,060 | 13,009 | 2,039 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Namio Matsumoto | Chairman | Executive Board | 2014 | 82 |
| Kiyoo Matsumoto | President; Director | Executive Board | 2014 | 52 |
| Takashi Matsumoto | Senior Managing Director; Head- Sales Planning; Director | Executive Board | 2023 | 50 |
| Shingo Obe | Director; Head- Management | Executive Board | 2022 | 63 |
| Tsuyoshi Yamamoto | Head, Group Business Planning; Director | Executive Board | 2021 | 58 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer